DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2237396/should-you-buy-red-hot-stocks-now-or-wait?cid=CS-ZC-FT-market_edge-2237396 Mar 07, 2024 - After a mesmerizing rally to start 2024, is it too late to buy the hottest stocks? 0

https://www.zacks.com/stock/news/2236096/nektar-nktr-q4-loss-wider-than-expected-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2236096 Mar 05, 2024 - Nektar (NKTR) reports a wider-than-expected loss in the fourth quarter of 2023 while revenue beat estimates. 0

https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001 Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring. 0

https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353 Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS). 0

https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/?source=iedfolrf0000001 Feb 19, 2024 - These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects. 0

https://www.zacks.com/commentary/2226833/top-stock-reports-for-mastercard-sap-crowdstrike?cid=CS-ZC-FT-research_daily-2226833 Feb 15, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), SAP SE (SAP) and CrowdStrike Holdings, Inc. (CRWD). 0

https://www.zacks.com/stock/news/2225655/incyte-s-incy-q4-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2225655 Feb 13, 2024 - Incyte's (INCY) fourth-quarter 2023 earnings and revenues miss estimates. Quarterly revenues cross the $1 billion mark for the first time on the continued growth of Jakafi and the strong launch of Opzelura. 0

https://www.fool.com/investing/2024/02/12/this-unstoppable-growth-stock-just-announced-more/?source=iedfolrf0000001 Feb 12, 2024 - The drugmaker continues to impress investors. 0

https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001 Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years. 0

https://www.zacks.com/stock/news/2224190/pharma-stock-roundup-azn-lly-s-q4-earnings-nvo-nvs-mrk-s-m-a-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-2224190 Feb 09, 2024 - Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements. 0